Searched over 200M research papers
5 papers analyzed
Some studies suggest that lisinopril is more effective in reducing blood pressure, while other studies indicate that quinapril is more effective or that both drugs have similar efficacy and tolerance.
5 papers analyzed
20 papers analyzed
Quinapril and lisinopril are both angiotensin-converting enzyme (ACE) inhibitors used to treat hypertension. While they share a common mechanism of action, their efficacy and safety profiles can differ.
Several studies have compared the efficacy of lisinopril and quinapril in patients with mild to moderate hypertension. One study found that lisinopril normalized blood pressure in 83% of patients, compared to 45% for quinapril, indicating a superior efficacy for lisinopril in reducing blood pressure over a 4 to 8-week period. Another study supported these findings, showing that lisinopril led to a more significant reduction in both systolic and diastolic blood pressure compared to quinapril when measured using ambulatory blood pressure monitoring (ABPM) .
In a 12-week study, both drugs were effective in reducing systolic and diastolic blood pressure. However, quinapril showed a greater reduction in systolic blood pressure at week 4 and in diastolic blood pressure at week 8 compared to lisinopril. Despite this, lisinopril was more effective in maintaining blood pressure control over a 24-hour period, as quinapril's efficacy diminished after 12 hours.
Both drugs were generally well-tolerated. However, some differences in side effects and biochemical changes were noted. For instance, a study reported a significant reduction in heart rate in the quinapril group, which was not observed in the lisinopril group. Additionally, both drugs caused an increase in serum potassium levels, but no significant differences were found between the two groups in this regard.
In elderly patients with low blood renin levels, both quinapril and lisinopril were effective and well-tolerated. However, quinapril provided a more effective and consistent control of hypertension in this demographic.
While both quinapril and lisinopril are effective ACE inhibitors for treating hypertension, lisinopril generally shows superior efficacy in reducing and maintaining lower blood pressure levels over time. Quinapril, on the other hand, may offer better initial reductions in blood pressure and heart rate but may not sustain these effects as well as lisinopril. Both medications are well-tolerated, with some differences in side effects and biochemical changes. Therefore, the choice between quinapril and lisinopril may depend on individual patient needs and response to treatment.
Most relevant research papers on this topic